ID

12877

Description

EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol; ODM derived from: https://clinicaltrials.gov/show/NCT01119261

Link

https://clinicaltrials.gov/show/NCT01119261

Keywords

  1. 1/4/16 1/4/16 -
Uploaded on

January 4, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Venous Thromboembolism NCT01119261

Eligibility Venous Thromboembolism NCT01119261

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
Description

venous thromboembolism; atrial fibrillation; coumarin

Data type

boolean

Alias
UMLS CUI [1]
C1861172
UMLS CUI [2]
C0004238
UMLS CUI [3]
C0010206
age ≥ 18 years
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
ability to attend scheduled visits
Description

compliance behavior

Data type

boolean

Alias
UMLS CUI [1]
C1321605
signed informed consent
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of a mechanical heart valve
Description

mechanical heart valve

Data type

boolean

Alias
UMLS CUI [1]
C0493527
severe cognitive impairment
Description

cognitive impairment

Data type

boolean

Alias
UMLS CUI [1]
C1839000
known genotype cyp2c9 or vkorc1 at start of the study
Description

genotype CYP2 gene VKOR gene

Data type

boolean

Alias
UMLS CUI [1,1]
C0017431
UMLS CUI [1,2]
C1332829
UMLS CUI [1,3]
C1428184
previous or current treatment with any coumarin
Description

therapy coumarin

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0010206
pregnancy or lactation
Description

pregnancy; lactating

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
non-eligible subject
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Venous Thromboembolism NCT01119261

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
venous thromboembolism; atrial fibrillation; coumarin
Item
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
boolean
C1861172 (UMLS CUI [1])
C0004238 (UMLS CUI [2])
C0010206 (UMLS CUI [3])
age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
compliance behavior
Item
ability to attend scheduled visits
boolean
C1321605 (UMLS CUI [1])
informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
mechanical heart valve
Item
presence of a mechanical heart valve
boolean
C0493527 (UMLS CUI [1])
cognitive impairment
Item
severe cognitive impairment
boolean
C1839000 (UMLS CUI [1])
genotype CYP2 gene VKOR gene
Item
known genotype cyp2c9 or vkorc1 at start of the study
boolean
C0017431 (UMLS CUI [1,1])
C1332829 (UMLS CUI [1,2])
C1428184 (UMLS CUI [1,3])
therapy coumarin
Item
previous or current treatment with any coumarin
boolean
C0087111 (UMLS CUI [1,1])
C0010206 (UMLS CUI [1,2])
pregnancy; lactating
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
non-eligible subject
boolean
C2348568 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial